货号:A832489
同义名:
1,24(R)-Dihydroxyvitamin D3 monohydrate; 1,24-dihydroxy Vitamin D3 (hydrate)
Tacalcitol monohydrate通过调节钙水平促进正常骨骼发育。
HazMat Fee + There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.
| Type | HazMat fee for 500 gram (Estimated) |
| Excepted Quantity | USD 0.00 |
| Limited Quantity | USD 15-60 |
| Inaccessible (Haz class 6.1), Domestic | USD 80+ |
| Inaccessible (Haz class 6.1), International | USD 150+ |
| Accessible (Haz class 3, 4, 5 or 8), Domestic | USD 100+ |
| Accessible (Haz class 3, 4, 5 or 8), International | USD 200+ |


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 描述 | Tacalcitol promotes normal bone development by regulating calcium. |
| Concentration | Treated Time | Description | References | |
| MDA-MB-231 cells | 100 nM | 120 hours | To evaluate the antiproliferative effect of Tacalcitol on MDA-MB-231 cells, results showed that Tacalcitol combined with anastrozole significantly inhibited cell proliferation. | Int J Mol Sci. 2021 Mar 9;22(5):2781 |
| SKBR-3 cells | 100 nM | 120 hours | To evaluate the antiproliferative effect of Tacalcitol on SKBR-3 cells, results showed that Tacalcitol combined with anastrozole significantly inhibited cell proliferation. | Int J Mol Sci. 2021 Mar 9;22(5):2781 |
| T47D cells | 10 nM | 120 hours | To evaluate the antiproliferative effect of Tacalcitol on T47D cells, results showed that Tacalcitol combined with anastrozole significantly inhibited cell proliferation. | Int J Mol Sci. 2021 Mar 9;22(5):2781 |
| MCF-7 cells | 100 nM | 120 hours | To evaluate the antiproliferative effect of Tacalcitol on MCF-7 cells, results showed that Tacalcitol combined with anastrozole significantly inhibited cell proliferation. | Int J Mol Sci. 2021 Mar 9;22(5):2781 |
| HL-60 cells | 8 nM | 120 hours | To evaluate the antiproliferative effect of Tacalcitol on HL-60 cells, results showed significant antiproliferative activity. | Cancers (Basel). 2022 Jan 13;14(2):387 |
| Thp-1 cells | 6 nM | 120 hours | To evaluate the antiproliferative effect of Tacalcitol on Thp-1 cells, results showed significant antiproliferative activity. | Cancers (Basel). 2022 Jan 13;14(2):387 |
| MV-4-11 cells | 3 nM | 120 hours | To evaluate the antiproliferative effect of Tacalcitol on MV-4-11 cells, results showed significant antiproliferative activity. | Cancers (Basel). 2022 Jan 13;14(2):387 |
| MC38/0 cells | 100 nM | 120 hours | To evaluate the antiproliferative effect of Tacalcitol (PRI-2191) in combination with 5-FU on MC38/0 cells. Results showed that PRI-2191 significantly enhanced the antiproliferative effect of 5-FU on MC38/0 cells. | BMC Cancer. 2013 Jun 18;13:294 |
| HT-29 cells | 100 nM | 120 hours | To evaluate the antiproliferative effect of Tacalcitol (PRI-2191) in combination with 5-FU on HT-29 cells. Results showed that PRI-2191 significantly enhanced the antiproliferative effect of 5-FU on HT-29 cells. | BMC Cancer. 2013 Jun 18;13:294 |
| MV-4-11 | 10 nM | 48-120 hours | Increased proportion of cells in G1/G0 phase, decreased proportion in S phase | Int J Mol Sci. 2022 Apr 30;23(9):5019 |
| 67NR cells | 100 nM | 72 hours | To evaluate the effect of Tacalcitol and its analogs on the proliferation of 67NR cells. The results showed that Tacalcitol and its analogs significantly inhibited the proliferation of 67NR cells. | Int J Oncol. 2018 Jan;52(1):103-126 |
| 4T1 cells | 100 nM | 72 hours | To evaluate the effect of Tacalcitol and its analogs on the proliferation of 4T1 cells. The results showed that Tacalcitol and its analogs did not significantly affect the proliferation of 4T1 cells. | Int J Oncol. 2018 Jan;52(1):103-126 |
| HL-60 | 10 nM | 72 hours | Increased proportion of cells in G1/G0 phase, decreased proportion in S phase | Int J Mol Sci. 2022 Apr 30;23(9):5019 |
| MCF-7 cells | 1000, 100, 10, 1 nM | 72 hours | To evaluate the antiproliferative activity of Tacalcitol (PRI-2191) against MCF-7 breast cancer cells. Results showed that Tacalcitol significantly inhibited cell proliferation at 100 nM concentration. | Cancers (Basel). 2013 Oct 31;5(4):1355-78 |
| Thp-1 | 10 nM | 96 hours | Increased proportion of cells in G1/G0 phase, decreased proportion in S phase | Int J Mol Sci. 2022 Apr 30;23(9):5019 |
| Administration | Dosage | Frequency | Description | References | ||
| C57BL/6 female mice | MC38 mouse colon cancer model | Subcutaneous injection | 1 μg/kg/day | Three times a week, until the end of the experiment | To evaluate the antitumor effect of Tacalcitol (PRI-2191) in combination with 5-FU on the MC38 mouse colon cancer model. Results showed that the combined treatment significantly inhibited tumor growth and prolonged the survival time of mice. | BMC Cancer. 2013 Jun 18;13:294 |
| BALB/c mice | 4T1 mammary tumor model | Subcutaneous injection | 1.0 µg/kg | Three times a week, starting from day 7 after tumor inoculation | To assess the effect of Tacalcitol on Th17 cells in the 4T1 tumor model in young and aged OVX mice. Results showed that Tacalcitol increased Th17 cell gene expression and IL-17A secretion in young mice but decreased these effects in aged OVX mice. | Aging Dis. 2020 Mar 9;11(2):241-253 |
| SCID mice | MCF-7 breast cancer model | Subcutaneous injection | 1.0 μg/kg | Three times a week for 46 days | To evaluate the antitumor effect of Tacalcitol in vivo on MCF-7 tumor growth, results showed that Tacalcitol significantly inhibited tumor growth. | Int J Mol Sci. 2021 Mar 9;22(5):2781 |
| NU/J mice | Subcutaneous human breast MCF-7 tumor model | Subcutaneous injection | 1.0 μg/kg/day | Three times a week, up to day 67 of the experiment | To evaluate the antitumor activity of Tacalcitol (PRI-2191) in the MCF-7 breast cancer model. Results showed that PRI-2191 significantly inhibited tumor growth on days 60 and 62 of the experiment. | Cancers (Basel). 2013 Oct 31;5(4):1355-78 |
| BALB/c female mice | 4T1 mouse mammary gland cancer model | Subcutaneous injection | PRI-2191, 1.0 µg/kg | Thrice a week, starting from day 7 after tumor inoculation | To evaluate the effect of Tacalcitol analog PRI-2191 on tumor growth and metastasis in the 4T1 mouse mammary gland cancer model. The results showed that PRI-2191 did not influence the growth of primary tumors but significantly increased lung metastasis. | Int J Oncol. 2018 Jan;52(1):103-126 |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
2.30mL 0.46mL 0.23mL |
11.50mL 2.30mL 1.15mL |
23.01mL 4.60mL 2.30mL |
|
| CAS号 | 93129-94-3 |
| 分子式 | C27H46O4 |
| 分子量 | 434.65 |
| SMILES Code | CC([C@@H](CC[C@H]([C@@H](CC[C@]1/2[H])[C@@]1(C)CCCC2=C/C=C3C[C@@H](C[C@H](C/3=C)O)O)C)O)C.[H]O[H] |
| MDL No. | MFCD13184757 |
| 别名 | 1,24(R)-Dihydroxyvitamin D3 monohydrate; 1,24-dihydroxy Vitamin D3 (hydrate); TV 02; Tacalcitol; PRI 2191; 1α,24(R)-Dihydroxycholecalciferol; Curatoderm; Bonalfa |
| 运输 | 蓝冰 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Sealed in dry, store in freezer, under -20°C |
沪公网安备 31011702889066号
沪ICP备2024050318号-1